Skip to main content
Program
#AHA25
Late-Breaking Science
Daily Coverage
Industry Highlights
Photo Gallery
Journeys
Latest Stories from Scientific Sessions
AHA CEO: Driving breakthroughs
AHA CEO describes how to continue to deliver on the AHA mission during its second century.
Wake-up call: Heeding global risk factors
Scientific Sessions 2024 Daily News coverage
AI medical company wins global health tech competition at #AHA24
LBS 08: Advances in lipid therapeutics
LBS 07: New approaches to managing AFib
Combined linear ablation, radiofrequency ablation, metformin and aggressive risk factor management.
LBS 06: Medical therapy for heart failure
Myeloperoxidase inhibitor, Sacubitril-Valsartan, standard loop diuretic and sodium zirconium cyclosilicate and spironolactone.
Sponsored
Lp(a) and Peripheral Artery Disease Toolkit
This toolkit raises awareness of Lp(a), why it is important to measure in addition to LDL, how Lp(a) intersects with PAD and more.
LBS 05: Innovation in prevention
Two-drug polypills, electronic nudges, ZODIAC and pacemakers.
Managing patients with symptomatic mitral or tricuspid regurgitation
Discussion explores the role M-TEER and T-TEER play.
Environmental crises call for more CV research
Pollution, rising temperatures can have a big impact on health.
Interesting Stories
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Streamlining the pathway to publish cardiovascular research
Starting in 2025, research authors will have the option to select a seamless transfer of their manuscript between NEJM and Circulation.
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Paul Dudley White Lecture lays groundwork for promising patient outcomes.
LBS 04: Coronary and valvular heart disease
Liberal or restrictive oxygenation, GLP-1 agonist therapy, edoxaban and spironolactone.
LBS 03: Harnessing AI for better heart health
Improving guideline-directed medical therapy, comparing wearable versus implanted sensors, boosting echocardiogram performance and automating echocardiographic interpretation.
Improving patient outcomes for sudden cardiac arrest
Technology-enhanced prediction tools, public awareness and training are key.
LBS 02: Redefining arrhythmia treatment
Catheter ablation, OPTION and Brain-AF.
At the intersection of heart and brain
Collaborating across the Atlantic on critical care cardiology
Early Career Investigator Showcase illuminates paths forward in research
Nurses drive programs, clinics to treat heart disease
What women want: Better cardiovascular health
Watch AHAtv
See AHAtv now
AHA selects six Distinguished Scientists for 2024
Q&A: Research Goes Red recognition
Challenged by rare cardiomyopathies
Aspirin's staying power
Clinical Guideline Sessions
Shuttle Service to Convention Center
